Sterling Investment Counsel LLC Sells 1,000 Shares of Cardinal Health, Inc. $CAH

Sterling Investment Counsel LLC trimmed its stake in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 8.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,364 shares of the company’s stock after selling 1,000 shares during the quarter. Cardinal Health makes up 1.1% of Sterling Investment Counsel LLC’s investment portfolio, making the stock its 17th largest position. Sterling Investment Counsel LLC’s holdings in Cardinal Health were worth $1,909,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Cardinal Health by 3.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock valued at $297,000 after purchasing an additional 62 shares during the period. Perigon Wealth Management LLC raised its holdings in Cardinal Health by 3.2% during the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock valued at $389,000 after buying an additional 72 shares during the last quarter. Community Bank & Trust Waco Texas boosted its position in Cardinal Health by 1.3% during the 2nd quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock valued at $940,000 after buying an additional 74 shares during the period. Pinnacle Bancorp Inc. boosted its position in Cardinal Health by 11.2% during the 1st quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company’s stock valued at $106,000 after buying an additional 77 shares during the period. Finally, G&S Capital LLC grew its holdings in Cardinal Health by 0.8% in the 2nd quarter. G&S Capital LLC now owns 9,476 shares of the company’s stock worth $1,592,000 after acquiring an additional 78 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $158.50 on Friday. The firm has a market capitalization of $37.66 billion, a P/E ratio of 24.57, a P/E/G ratio of 1.34 and a beta of 0.71. The stock has a 50 day moving average price of $152.12 and a 200-day moving average price of $150.09. Cardinal Health, Inc. has a 52-week low of $106.98 and a 52-week high of $168.44.

Cardinal Health (NYSE:CAHGet Free Report) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Analyst Ratings Changes

Several brokerages have recently commented on CAH. Evercore ISI lowered their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Bank of America upped their price target on Cardinal Health from $165.00 to $170.00 and gave the company a “buy” rating in a research report on Tuesday, June 10th. Wells Fargo & Company reiterated an “overweight” rating and issued a $185.00 price objective (up previously from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Argus set a $189.00 price target on Cardinal Health in a research note on Friday, August 22nd. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $165.93.

Get Our Latest Stock Report on CAH

Insider Activity at Cardinal Health

In related news, CEO Jason M. Hollar sold 107,705 shares of the business’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the sale, the chief executive officer owned 235,901 shares of the company’s stock, valued at $35,125,658.90. The trade was a 31.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the transaction, the insider directly owned 48,457 shares of the company’s stock, valued at $7,211,370.74. This represents a 44.00% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 over the last 90 days. 0.12% of the stock is currently owned by insiders.

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Further Reading

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.